Edition:
India

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

119.00EUR
19 Jan 2018
Change (% chg)

€-0.20 (-0.17%)
Prev Close
€119.20
Open
€117.80
Day's High
€119.40
Day's Low
€117.40
Volume
12,198
Avg. Vol
15,005
52-wk High
€177.20
52-wk Low
€102.10

Select another date:

Tue, Jan 16 2018

BRIEF-Virbac Q4 Sales Up At 231.5 Million Euros

* ANNUAL SALES COMPARABLE TO 2016 AT CONSTANT EXCHANGE RATES AFTER STRONG FOURTH-QUARTER GROWTH

BRIEF-Virbac postpones its option to buy Centrovet for three years

* REG-VIRBAC : AQUACULTURE: VIRBAC POSTPONES ITS OPTION TO BUY CENTROVET FOR THREE YEARS

BRIEF-Virbac Q3 sales fall to 192.7 million euros

* REG-VIRBAC: QUARTERLY SALES AFFECTED BY DISTRIBUTOR DESTOCKING IN THE UNITED STATES

Virbac cuts full-year revenue forecast amid still weak US sales

Sept 11 French veterinary pharmaceutical firm Virbac cut its full-year outlook on Monday, saying it now expected revenue to be little changed from last year after a fall in U.S. sales affected its first-half earnings.

BRIEF-Virbac H1 net profit group share rises to 13.9 ‍million euros

* H1 NET PROFIT GROUP SHARE EUR 13.9 ‍​MILLION VERSUS EUR 13.1 MILLION YEAR AGO

BRIEF-Creso Pharma signs commercialisation agreement with Virbac

* Signed a commercialisation agreement with Virbac, for the launch of its hemp‐based complementary animal feed products Source text for Eikon: Further company coverage:

Select another date: